Sources | Names Used |
---|---|
CTRPv2 | carboplatin:etoposide (40:17 mol/mol) |
PharmacoGx | carboplatin:etoposide (40:17 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUCKS1 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-16 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-16 |
mRNA | HNRNPH1 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-16 |
mRNA | CPSF6 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-16 |
mRNA | TMPO | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-15 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-15 |
mRNA | MDM4 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-15 |
mRNA | IPO9 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-15 |
mRNA | SFPQ | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-15 |
mRNA | DENND6A | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-15 |